Last Updated on Sep 18, 2020

Rules and compensation

Although reproductive medicine is a branch of medicine it requires to be treated specially and with caution.

Many western countries pertain to the rules and standards of regulatory bodies, such as HEFA and ESHREE, that dictate the functioning of fertility medicine. Several countries, such as the USA and UK have formulated their own ‘egg sale’ policies. In the USA, research using human eggs, has the support of the government. Women may, therefore, donate for both reproduction and research. However, the donors who contribute eggs for the purpose of reproduction are paid exorbitantly, while those who donate their eggs for research are barely reimbursed.

Policy makers content that this disparity is to prevent exploitation of women who belong to certain ethnicity, color and financial background. The potential for commodification has alerted US scientists who have pledged that SCNT will not be carried out on purchased human eggs. Therefore research using human eggs is solely dependent on altruistically donated eggs.

In India, fertility medicine is a lucrative enterprise with almost all cities boasting of several fertility centers. However these centers are being given the ‘free run’, with no regulatory body or rules to monitor or control them. In 2002-2003 a 19-member team belonging to the Indian Council of Medical Research (ICMR) drafted national guidelines, with a proposal for legislation of the same.

Two of the highlights of the guidelines are:

  • Egg / sperm donation and surrogacy among blood relatives and friends is banned
  • Offspring has the right to know the identity of the donor of egg or sperm

Many feel that the first clause is likely to commodify human gametes, while the second clause will infringe on the right to privacy of the donor. Medical experts have asked for these proposals to be reconsidered, as they are likely to increase the current paucity for donors. A public debate must be called, and opinions from various people belonging to different sectors must be endorsed before converting these guidelines into laws.


baby2mom Saturday, October 16, 2010

The concept of egg donation risk is always relevant for egg donors and recipients of these donor eggs. The world is becoming more ethical and people do not want to embark on any thing which will pose potential harm to a person willing to do good.

For donors, their fertility is not adversely impacted. The period on hormone treatment is for a minimal period and egg donors are carefully assessed during this short period to ascertain whether the medication should be increased or lowered in accordance with her body's response to the stimulation.

In the event that a woman experiences some challenges with conception or fertility later in life after the donor program, it is not likely a consequence to this. Examples include uterine or tubal problems. The screening process for a program requires review of the ovaries, not necessarily the entire reproductive system. Also, sperm plays a role.

The actual retrieval of the eggs is a vaginal process undertaken either under sedation or general anaesthetic. This is also not a risky process. Donor eggs retrieval or harvesting is not an operation, rather an extraction of the eggs from the follicles of the ovaries. This does not involve any cutting or scarring of the ovarian tissue.

After this program, the ovaries will appear slightly different, but not unnatural, just like they have been stimulated. Egg donors are encouraged to remain in contact with the medical practitioner in the event of any concerns.

There is no increased risk for a person receiving eggs. There is extensive screening for people who donate on all levels - by the agency, social level and medical review.

guest Monday, April 16, 2007

The Useful Information for all the viewers

Most Popular on Medindia